Affiliations 

  • 1 Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM), 25200, Kuantan, Malaysia
  • 2 Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM), 25200, Kuantan, Malaysia. mdrahman@iium.edu.my
  • 3 Faculty of Pharmacy, Cyberjaya University College of Medical Sciences, 63000, Cyberjaya, Malaysia
  • 4 Drug Delivery and Novel Targeting Research Group, Centre for Drug Delivery Research, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia
  • 5 Kulliyyah of Science, International Islamic University Malaysia, 25200, Kuantan, Malaysia
Arch Pharm Res, 2016 Sep;39(9):1242-56.
PMID: 26818028 DOI: 10.1007/s12272-016-0710-3

Abstract

The aim of this study was to prepare a model protein, bovine serum albumin (BSA) loaded double-walled microspheres using a fast degrading glucose core, hydroxyl-terminated poly(lactide-co-glycolide) (Glu-PLGA) and a moderate-degrading carboxyl-terminated PLGA polymers to reduce the initial burst release and to eliminate the lag phase from the release profile of PLGA microspheres. The double-walled microspheres were prepared using a modified water-in-oil-in-oil-in-water (w/o/o/w) method and single-polymer microspheres were prepared using a conventional water-in-oil-in-water (w/o/w) emulsion solvent evaporation method. The particle size, morphology, encapsulation efficiency, thermal properties, in vitro drug release and structural integrity of BSA were evaluated in this study. Double-walled microspheres prepared with Glu-PLGA and PLGA polymers with a mass ratio of 1:1 were non-porous, smooth-surfaced, and spherical in shape. A significant reduction of initial burst release was achieved for the double-walled microspheres compared to single-polymer microspheres. In addition, microspheres prepared using Glu-PLGA and PLGA polymers in a mass ratio of 1:1 exhibited continuous BSA release after the small initial burst without any lag phase. It can be concluded that the double-walled microspheres made of Glu-PLGA and PLGA polymers in a mass ratio of 1:1 can be a potential delivery system for pharmaceutical proteins.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.